Transcranial direct current stimulation is safe, effective, and tolerable as an add-on treatment for patients already receiving pharmacologic therapy for bipolar depression (BD), according to researchers in Brazil. Study results were published in JAMA Psychiatry. Read more here.
Exploring Safe and Effective Treatments for Bipolar Depression: Transcranial Direct Current Stimulation
Study Identifies New Target for Treatment of Depression
New Study seeks to identify the specific strain (out of 14) that serves as a modulator of serotonin receptors. As Julia Castello, a graduate student at CUNY says, “Identifying new targets broadens our understanding about the cause of depression as well as the mechanism of action of antidepressants.” Read more here.
Magic Mushrooms Could Treat Depression Without the Emotional Numbing Caused by Traditional Antidepressants
New Research has found that ‘magic mushrooms’ could hold the key to alleviating symptoms of depression, particularly in those who have not seen benefits in more traditional treatments. Read more here.
LivaNova Commences Global RESTORE-LIFE Study for Treatment Resistant Depression
Livanova PLC has announced the launch and enrollment of the first patient for its observational post-market study to assess the effectiveness of its Vagus Nerve Stimulation Therapy. The study will assess the short, medium and long term impact of ‘VNS Therapy’ on those suffering from treatment resistant depression. Read the article here.
Leveraging Smartphones in Patient Care
Interesting article published by two doctors considering the potential impact of smartphones to help monitor information relevant to mental illness. Smart phones have become ubiquitous in Western society and are increasingly penetrating developing spaces so there is a lot of potential to exploit the extensive reach of this technology. Read the article here.
Dual Diagnosis: Why Substance Abuse Worsens Your Mental Health
Blog posted by experts from the Cleveland Clinic briefs the different factors that lead to high rates of ‘co-occurrence’, ie instances of both mental illness and substance abuse. It also clearly points out that though the problems associated with both can be overwhelming due to their overlapping, interwoven and mutually reinforcing tendencies, there are plenty of options to help treat the illness. Read the blog here.
Biotech Sage Therapeutics Skyrockets More Than 70 Percent After Depression Drug Breakthrough
Sage Therapeutics said in a release that 64 percent of patients achieved Major Depression Disorder remission using the SAGE-217 drug in the 15th day of treatment. Read the article here.
Light Therapy May Improve Symptoms of Bipolar Depression
This article in Healthline details a study, and expert reactions to its findings, in which preliminary results demonstrate that Light Therapy shows promise for treating bi-polar depression. Read it here.
Depression Tied to Shorter Life Span
While the title of the article is distressing, the actual findings of the study do provide hope that proper treatment can counteract the threats to longevity that mental illness poses. Read more here.
Floating Away Your Anxiety and Stress
This new treatment seeks to combat stress and anxiety-as well as related symptoms such as increased blood pressure and racing mental activity-by allowing patients to float in extremely salinated water for around an hour at a time. The treatment is still in its testing phases but has proven to be an attractive alternative to medication for many suffering from PTSD, injured athletes, and those suffering from chronic pain and anxiety. Read the NPR article here.
Featured In:
Built by Staple Creative